<p>/PRNewswire/ -- CQ Medical，全球領先的患者放射治療定位和醫療創新公司，自豪地宣佈收購 Bionix 的放射治療業務部門，這標誌着其患者定位和標記產品組合的擴展。這次收購強化了 CQ Medical 推進放射治療精準度的使命，賦能臨牀醫生並改善全球患者的治療效果。</p>
<p>Bionix 在過去 40 多年中在多個患者護理領域開發創新、高質量醫療設備方面建立了強大的聲譽。在 CQ 收購放射治療業務部門後，Bionix 將繼續獨立運營其位於俄亥俄州莫米的門診護理業務部門，專注於耳鼻喉護理解決方案。</p>
<p>CQ Medical 成立於 2022 年，由 CIVCO Radiotherapy 和 Qfix 合併而成，匯聚了在先進放射治療定位和固定解決方案方面的數十年專業知識。CQ Medical 的產品組合涵蓋多種臨牀應用，包括用於精確立體定向治療和質子治療的設備、用於影像引導放射治療的可植入標記物、可定製的熱塑性患者固定裝置，以及用於放射治療和介入心臟病學與放射學程序的患者轉運系統。</p>
<p>&#34;Bionix 的放射治療收購為 CQ Medical 帶來了幾條互補的產品線，同時也增加了來自 Bionix 組織的強大商業團隊，&#34;CQ Medical 首席執行官 Michael Galbus 表示。&#34;我們期待與我們的臨牀合作伙伴繼續合作，支持下一代研究和新產品開發。&#34;</p>
<p>來自 Bionix 總裁兼首席執行官 Chris Becker 的聲明 – &#34;CQ Medical 在放射腫瘤學市場上備受尊重，我們相信他們是繼續以最高水平的創新、服務和產品質量支持放射治療客户的合適合作伙伴。這個決定使 Bionix 能夠將全部精力和投資集中在我們的核心門診護理業務上——包括初級護理、急救護理、聽力學和耳鼻喉科。&#34;</p>
<p>在接下來的幾個月裏，CQ Medical 將開始將 Bionix 的放射治療產品線和運營轉移到其現有的製造地點。這一整合過程將確保客户服務和產品支持的無縫連續性，同時保持兩個組織所堅持的質量標準。</p>
<p>有關更多信息，請訪問 CQmedical.com 或在 LinkedIn 和 Facebook 上與 CQ Medical 聯繫。</p>
<p>版權所有 © 2025 CQ Medical。保留所有權利。CQ Medical 是 CQ Medical 的註冊商標。</p>
<p>來源 CQ Medical</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAxJk5ld3NJdGVtSWQ9Q0czNTk3OCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDExMzA3UFJfTkVXU19VU1BSX19fX19DRzM1OTc4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAxJk5ld3NJdGVtSWQ9Q0czNTk3OCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDExMzA3UFJfTkVXU19VU1BSX19fX19DRzM1OTc4"/></p>

<p>CQ Medical 已收購 Bionix 的放射治療業務部門，擴展其放射治療產品組合。這項收購增強了 CQ Medical 在放射治療方面的精準度，增加了互補的產品線和強大的商業團隊。Bionix 將繼續獨立運營其門診護理業務。整合將確保無縫的客户服務和產品支持。CQ Medical 旨在推動放射治療領域的研究和新產品開發</p>

<p>, /PRNewswire/ -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy business unit, marking an expansion of its patient positioning and marking product portfolio. The acquisition reinforces CQ Medical's mission to advance precision in radiotherapy, empowering clinicians and improving outcomes worldwide.</p>
<div class="lb-trans"><p>/PRNewswire/ -- CQ Medical，全球領先的患者放射治療定位和醫療創新公司，自豪地宣佈收購 Bionix 的放射治療業務部門，這標誌着其患者定位和標記產品組合的擴展。這次收購強化了 CQ Medical 推進放射治療精準度的使命，賦能臨牀醫生並改善全球患者的治療效果。</p>
</div><p>Bionix has established a strong reputation of developing innovative, high-quality medical devices across multiple patient care segments for over 40 years. Following CQ's acquisition of the Radiation Therapy business unit, Bionix will continue to operate its Ambulatory Care business unit, which specializes in Ear, Nose, and Throat care solutions, independently out of its Maumee, Ohio headquarters.</p>
<div class="lb-trans"><p>Bionix 在過去 40 多年中在多個患者護理領域開發創新、高質量醫療設備方面建立了強大的聲譽。在 CQ 收購放射治療業務部門後，Bionix 將繼續獨立運營其位於俄亥俄州莫米的門診護理業務部門，專注於耳鼻喉護理解決方案。</p>
</div><p>CQ Medical was formed in 2022 through the combination of CIVCO Radiotherapy and Qfix, bringing together decades of expertise in advanced radiation therapy positioning and immobilization solutions. The CQ Medical portfolio covers a range of clinical applications, including devices for precision stereotactic treatment and proton therapy, implantable fiducial markers for image-guided radiotherapy, customizable thermoplastic patient immobilization, and patient transfer systems for radiotherapy and interventional cardiology &amp; radiology procedures.</p>
<div class="lb-trans"><p>CQ Medical 成立於 2022 年，由 CIVCO Radiotherapy 和 Qfix 合併而成，匯聚了在先進放射治療定位和固定解決方案方面的數十年專業知識。CQ Medical 的產品組合涵蓋多種臨牀應用，包括用於精確立體定向治療和質子治療的設備、用於影像引導放射治療的可植入標記物、可定製的熱塑性患者固定裝置，以及用於放射治療和介入心臟病學與放射學程序的患者轉運系統。</p>
</div><p>&#34;The Bionix radiation therapy acquisition brings several complementary product lines to CQ Medical, as well as adding a strong commercial team from the Bionix organization,&#34; said Michael Galbus, CEO of CQ Medical. &#34;We look forward to the continued collaboration with our combined clinical partners to support the next generation of research and new product development.&#34;</p>
<div class="lb-trans"><p>&#34;Bionix 的放射治療收購為 CQ Medical 帶來了幾條互補的產品線，同時也增加了來自 Bionix 組織的強大商業團隊，&#34;CQ Medical 首席執行官 Michael Galbus 表示。&#34;我們期待與我們的臨牀合作伙伴繼續合作，支持下一代研究和新產品開發。&#34;</p>
</div><p>From Chris Becker, Bionix President and CEO – &#34;CQ Medical is deeply respected in the radiation oncology market, and we are confident they are the right partner to continue supporting the radiotherapy customers with the highest level of innovation, service, and product quality. This decision allows Bionix to focus our full attention and investment on our core Ambulatory Care business — including Primary Care, Urgent Care, Audiology, and ENT.&#34;</p>
<div class="lb-trans"><p>來自 Bionix 總裁兼首席執行官 Chris Becker 的聲明 – &#34;CQ Medical 在放射腫瘤學市場上備受尊重，我們相信他們是繼續以最高水平的創新、服務和產品質量支持放射治療客户的合適合作伙伴。這個決定使 Bionix 能夠將全部精力和投資集中在我們的核心門診護理業務上——包括初級護理、急救護理、聽力學和耳鼻喉科。&#34;</p>
</div><p>Over the coming months, CQ Medical will begin transitioning Bionix's radiation therapy product lines and operations into its existing manufacturing locations. This integration process will ensure seamless continuity in customer service and product support while maintaining the quality standards both organizations uphold.</p>
<div class="lb-trans"><p>在接下來的幾個月裏，CQ Medical 將開始將 Bionix 的放射治療產品線和運營轉移到其現有的製造地點。這一整合過程將確保客户服務和產品支持的無縫連續性，同時保持兩個組織所堅持的質量標準。</p>
</div><p>For additional information, please visit CQmedical.com or connect with CQ Medical on LinkedIn and Facebook.</p>
<div class="lb-trans"><p>有關更多信息，請訪問 CQmedical.com 或在 LinkedIn 和 Facebook 上與 CQ Medical 聯繫。</p>
</div><p>COPYRIGHT © 2025 CQ Medical. All rights reserved. CQ Medical is a registered trademark of CQ Medical.</p>
<div class="lb-trans"><p>版權所有 © 2025 CQ Medical。保留所有權利。CQ Medical 是 CQ Medical 的註冊商標。</p>
</div><p>SOURCE CQ Medical</p>
<div class="lb-trans"><p>來源 CQ Medical</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAxJk5ld3NJdGVtSWQ9Q0czNTk3OCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDExMzA3UFJfTkVXU19VU1BSX19fX19DRzM1OTc4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG35978&amp;Transmission_Id=202512011307PR_NEWS_USPR_____CG35978&amp;DateId=20251201"/></p>

CQ Medical®通過收購 Bionix 業務部門來擴展其放射治療產品組合